Company · CIK 1850838
Omega Therapeutics, Inc.
| CIK | 1850838 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-09-10 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-268254 | 2022-11-08 | 2025-03-25 | 5 | |
| 333-257794 | 2021-07-09 | 2021-08-02 | 4 |
Filings
10| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-03-25 | EFFECTDeclared effective | 333-268254 | 9999999995-25-000753 |
| 2023-08-03 | 424B5Shelf takedown | 333-268254 | 0001193125-23-202987 |
| 2023-02-23 | 424B5Shelf takedown | 333-268254 | 0001193125-23-046657 |
| 2022-11-18 | EFFECTDeclared effective | 333-268254 | 9999999995-22-003352 |
| 2022-11-08 | S-3Shelf registered | 333-268254 | 0001193125-22-280274 |
| 2021-08-02 | 424B4Final prospectus | 333-257794 | 0001193125-21-233242 |
| 2021-07-29 | EFFECTDeclared effective | 333-257794 | 9999999995-21-002980 |
| 2021-07-26 | S-1/AAmendment | 333-257794 | 0001193125-21-223570 |
| 2021-07-09 | S-1Registration filed | 333-257794 | 0001193125-21-211825 |
| 2021-05-10 | DRSDraft made public | 377-04819 | 0000950123-21-005617 |